Adaptimmune ‘Neck And Neck’ For First Solid Tumor T-Cell Therapy Nod For Afami-Cel

Company Looks Beyond Small Sarcoma Market For Afamitresgene Autoleucel

 
• By Alaric DeArment
  
T Cell lymphocyte with receptors for cancer cell immunotherapy research 3D render
Adaptimmune is reporting initial data from the SPEARHEAD-1 study of afami-cel at ASCO in June • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from ASCO

More from Conferences